• Profile
Close

Effect of administration of a proton pump inhibitor for ulcerative differentiated early gastric cancer prior to endoscopic submucosal dissection

Digestive Endoscopy Dec 11, 2020

Wang J, Shan F, Li S, et al. - Researchers conducted the study for analyzing the extent of ulcer healing and clinical effectiveness of proton pump inhibitor (PPI) administration for ulcerative differentiated early gastric cancer (EGC) prior to endoscopic submucosal dissection (ESD). A total of 214 ulcerative differentiated EGC patients treated with ESD were retrospectively examined, of which 129 were given PPI prior to ESD, and 85 were not. According to findings, the ulcer healing rate and complete ulcer healing rate varied significantly between the PPI and non‐PPI groups, respectively. Following PPI administration, partial or complete ulcer healing predicts differentiated EGC confined to the mucosa.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay